Home » BAVARIAN NORDIC A/S ENFORCES ITS INTELLECTUAL PROPERTY RIGHTS AGAINST ACAMBIS PLC AND ACAMBIS INC.
BAVARIAN NORDIC A/S ENFORCES ITS INTELLECTUAL PROPERTY RIGHTS AGAINST ACAMBIS PLC AND ACAMBIS INC.
August 22, 2005
Bavarian Nordic A/S announced today that it has filed a patent infringement action against Acambis plc's MVA smallpox vaccine products at the U.S. International Trade Commission based in Washington DC. If successful, Bavarian Nordic will be in a position to either stop Acambis from engaging in the importation of any infringing MVA smallpox vaccine products into the USA, or seek a royalty for each infringing dose of MVA smallpox vaccine imported to the USA.
U.S. Newswire (http://releases.usnewswire.com/GetRelease.asp?id=51908)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct